Please wait while we load the requested 40-F report or click the link below:
https://last10k.com/sec-filings/report/1734768/000117625621000077/imv40fex99-1.htm
March 2023
March 2023
February 2023
January 2023
December 2022
December 2022
December 2022
December 2022
December 2022
December 2022
Please wait while we load the requested 40-F report or click the link below:
https://last10k.com/sec-filings/report/1734768/000117625621000077/imv40fex99-1.htm
Compare this 40-F Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Imv Inc..
Imv Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 40-F Annual Report
Material Contracts, Statements, Certifications & more
Imv Inc. provided additional information to their SEC Filing as exhibits
Ticker: IMV
CIK: 1734768
Form Type: 40-F Annual Report
Accession Number: 0001176256-21-000077
Submitted to the SEC: Wed Mar 17 2021 7:40:55 AM EST
Accepted by the SEC: Wed Mar 17 2021
Period: Thursday, December 31, 2020
Industry: Pharmaceutical Preparations